Let CRISPR/Cas9 battle commence
11-03-2016
Editas goes public amid CRISPR patent battle
10-02-2016
CRISPR: the shifting sands of patentability
12-11-2015
The CRISPR patent war
09-04-2015
vitstudio / Shutterstock.com
Scientists from two US universities will fight out the ownership of the intellectual property rights to the CRISPR/Cas9 technology after the US Patent and Trademark Office (USPTO) agreed to initiate an interference proceeding.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
News stories up to a week old and feature articles on the day of publication are accessible with a BASIC FREE ACCOUNT.
Register here for free content, or subscribe for access to archive.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’; and for basic access to the latest news on the website and weekly email news alerts choose the 'BASIC FREE ACCOUNT' registration.
CRISPR/Cas 9; USPTO; Deborah Katz; Massachusetts Institute of Technology; University of California; gene-editing; DNA
